Table 6 |
||
|
Clinical and endocrine-metabolic characteristics of PCOS women according to TRB3 Q84R genotype |
||
|
QQ (n = 209) |
QR+ RR (n = 127) |
|
|
|
||
|
Age(yr) |
28 (17-40) |
28 (19-38) |
|
BMI(kg/m2) |
24 (16-33) |
25 (17-35) |
|
LH/FSH |
1.27 (0.01-5.2) |
1.48 (0.22-6.4) |
|
T(nmol/l) |
1.6 (0.21-7.11) |
1.7 (0.02-6.14) |
|
HOMA-IR |
2.2 (0.4-12.3) |
2.6 (0.4-12.8) |
|
glu0h(mmol/l) |
4.8 (3.5-8.7) |
4.9 (3.7-8.0) |
|
glu1h(mmol/l) |
7.4 (3.3-17.9) |
8.2 (3.4-60.1)* |
|
glu2h(mmol/l) |
6.2 (3.5-16.8) |
6.6 (3.4-50.8)* |
|
Ins0h(μIU/ml) |
9.7 (2.0-56.6) |
11.8 (2.0-45.8) |
|
Ins1h(μIU/ml) |
74.6 (1.2-300) |
86.8 (7.1-300) |
|
Ins2h(μIU/ml) |
67.3 (6.8-300) |
76.5 (6.7-300)* |
|
|
||
|
Mann-Whitney U-test; Data are described in median (range); HOMA-IR: homeostatic model assessment of insulin resistance;glu:glucose; Ins:insulin. *: p < 0.05. |
||
|
Zhang et al. Reproductive Biology and Endocrinology 2011 9:46 doi:10.1186/1477-7827-9-46 |
||
